Inhibrx, Inc. (INBX) Misses Q3 EPS by 71c

Inhibrx, Inc. (NASDAQ: INBX) reported Q3 EPS of ($2.28), $0.71 worse than the analyst estimate of ($1.57).

For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Boeing wins $174M in U.S. defense contracts for engines, training
• Parker-Hannifin (PH) Declares $2.00 Quarterly Dividend; 0.8% Yield